Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study - Concepedia

Concepedia

Publication | Closed Access

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

542

Citations

33

References

2000

Year

Steven A. Narod, Jean-Sébastien Brunet, Parviz Ghadirian, Mark E. Robson, Ketil Heimdal, Susan L. Neuhausen, Dominique Stoppa-Lyonnet, Caryn Lerman, Barbara Pasini, Patricia de los Rios,

Breast OncologyCancer RiskMedicineGynecologyPathologyBreast CancerContralateral Breast CancerOncologyBrca2 Mutation CarriersCase-control Study

References

	Year	Citations

Page 1

Page 1